EDRN Prostate MRI Biomarker Study

RecruitingOBSERVATIONAL
Enrollment

950

Participants

Timeline

Start Date

February 4, 2019

Primary Completion Date

June 30, 2028

Study Completion Date

December 31, 2028

Conditions
PSAProstate Cancer
Interventions
DIAGNOSTIC_TEST

MRI prostate

MRI and laboratory biomarkers

Trial Locations (1)

48109

RECRUITING

University of Michigan, Ann Arbor

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

The University of Texas Health Science Center at San Antonio

OTHER

collaborator

University of Alabama at Birmingham

OTHER

collaborator

University of Chicago

OTHER

collaborator

Cornell University

OTHER

collaborator

H. Lee Moffitt Cancer Center and Research Institute

OTHER

collaborator

Vanderbilt University

OTHER

collaborator

Emory University

OTHER

collaborator

University of Miami

OTHER

collaborator

University of Texas

OTHER

collaborator

Beth Israel Deaconess Medical Center

OTHER

collaborator

Brigham and Women's Hospital

OTHER

collaborator

Fred Hutchinson Cancer Center

OTHER

lead

University of Michigan

OTHER

NCT03784924 - EDRN Prostate MRI Biomarker Study | Biotech Hunter | Biotech Hunter